BioInsights - GMP compliant residual PEIpro® test: one step closer to commercialization

GMP compliant residual PEIpro® test: one step closer to commercialization

Cell & Gene Therapy Insights 2020; 6(10), 1455.

10.18609/cgti.2020.158

Published: 3 November 2020
FastFacts
Malik Hellal

Watch the video or read the poster to learn:

  • Why perform residual impurity testing?
  • How are critical raw materials quantified and detected?
  • How does the Residual PEIpro® test guarantee specific detection and accurate quantification of PEIpro® transfection reagent?


About the speaker

Malik Hellal is a Senior Scientist in Chemistry at Polyplus-transfection®. With a Ph.D. in Organic and Medicinal chemistry from the University of Strasbourg and post-doctoral experience at Harvard NeuroDiscovery Center, Malik is an expert in the conception and synthesis of biopolymers for the development of innovative targeted delivery solutions.


We hope you enjoyed this FastFacts video. You can also view the summary PDF here.